Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-29 Sale | 2024-03-01 5:49 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 8,661 | $1.58 | $13,684 | 706,932 (Direct) | View |
| 2024-02-29 Sale | 2024-03-01 5:48 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 5,974 | $1.58 | $9,439 | 663,259 (Direct) | View |
| 2024-02-29 Sale | 2024-03-01 5:47 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 46,570 | $1.58 | $73,581 | 2,364,436 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-01 5:46 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 7,169 | $1.58 | $11,327 | 695,840 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:03 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 7,411 | $1.52 | $11,265 | 669,233 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:02 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 10,744 | $1.52 | $16,331 | 715,593 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:01 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 8,367 | $1.52 | $12,718 | 703,009 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 6:00 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 37,733 | $1.52 | $57,354 | 2,411,006 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:10 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 46,489 | $1.68 | $78,102 | 3,353,939 (Indirect Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:10 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 24,311 | $1.68 | $40,842 | 1,014,676 (Direct) | View |
| 2023-05-25 Sale | 2023-05-25 9:01 pm | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 63,186 | $1.2229 | $77,270 | 724,344 (Direct) | View |
| 2023-05-25 Sale | 2023-05-25 9:01 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 95,478 | $1.2229 | $116,760 | 774,037 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 6:20 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 63,567 | $1.068 | $67,890 | 530,487 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 6:19 pm | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 63,567 | $1.068 | $67,890 | 446,483 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 91,868 | $0.8775 | $80,614 | 1,888,728 (Indirect Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 13,034 | $0.8775 | $11,437 | 287,530 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 14,123 | $0.8775 | $12,393 | 594,054 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:01 am | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 20,412 | $0.8775 | $17,912 | 269,515 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 08:00 am | Akebia Therapeutics Inc. | AKBA | Spellman David A SVP, CFO and Treasurer | 7,210 | $0.8775 | $6,327 | 510,050 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:07 pm | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 38,632 | $0.8132 | $31,416 | 1,980,596 (Indirect Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:06 pm | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 7,539 | $0.8132 | $6,131 | 608,177 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:06 pm | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 10,090 | $0.8132 | $8,205 | 289,927 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Option Award | 2024-02-02 4:11 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Grund Nicholas Chief Commercial Officer | 758,250 | $0 | 758,250 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:11 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Malabre Richard C Chief Accounting Officer | 559,950 | $0 | 559,950 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:11 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 373,300 | $0 | 950,337 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Snow Ellen SVP, CFO and Treasurer | 373,300 | $0 | 743,300 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 373,300 | $0 | 900,644 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President | 1,508,700 | $0 | 3,353,939 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:10 pm | N/A 2034-01-31 | Akebia Therapeutics Inc. | AKBA | Burke Steven Keith SVP, Chief Medical Officer | 505,500 | $0 | 1,014,676 (Direct) | View |
| 2023-07-31 Option Award | 2023-08-01 4:35 pm | N/A 2033-07-31 | Akebia Therapeutics Inc. | AKBA | Snow Ellen SVP, CFO and Treasurer | 930,000 | $0 | 930,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:08 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | ZUMWALT LEANNE M Director | 75,000 | $0 | 88,700 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:08 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | ROGERS MICHAEL W Director | 75,000 | $0 | 141,029 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | FRIESON RON Director | 75,000 | $0 | 88,700 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | Wolf Myles Director | 75,000 | $0 | 112,681 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 75,000 | $0 | 179,800 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | Smith Cynthia Director | 75,000 | $0 | 140,233 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | GILMAN STEVEN C Director | 75,000 | $0 | 132,130 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 9:01 pm | N/A 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 200,000 | $0 | 724,344 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 9:01 pm | N/A 2032-05-12 | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 200,000 | $0 | 774,037 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:10 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Hadas Nicole R. SVP, Chief Legal Officer | 100,000 | $0 | 387,530 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:09 pm | N/A N/A | Akebia Therapeutics Inc. | AKBA | Dahan Michel SVP, Chief Operating Officer | 200,000 | $0 | 469,515 (Direct) | View |